Sagent Pharmaceuticals Inc
(NASDAQ: SGNT)
+0.34
+2.09%
| Exchange: | NASDAQ |
| Stock: | Sagent Pharmaceuticals Inc |
| Industry: | NA |
| Employees: | 98 |
| Sagent Pharmaceuticals, Inc. (Sagent) is an injectable pharmaceutical company, which develops and sources products, which the Company sells in the United States. The Company offers its customers a range of products across anti-infective, oncolytic and critical care indications in a range of presentations, including single- and multi-dose vials, pre-filled ready-to-use syringes, medical devices and premix bags, and it focuses to develop injectable products. As of December 31, 2010, it marketed 22 products, all of which were generic injectable products, and had a pipeline, which included 46 new products represented by 77 Abbreviated New Drug Applications (ANDAs), which either are under review by the United States Food and Drug Administration (FDA) or were approved and their associated products are pending commercial launch. |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
